发明名称 |
METHODS FOR DOSING AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY |
摘要 |
Abstract The present invention relates to specific doses of and dosing regimens for using a 1,2,4 oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations. |
申请公布号 |
AU2013219243(A1) |
申请公布日期 |
2013.09.12 |
申请号 |
AU20130219243 |
申请日期 |
2013.08.23 |
申请人 |
PTC THERAPEUTICS, INC. |
发明人 |
HIRAWAT, SAMIT;MILLER, LANGDON |
分类号 |
A61K31/4245;A61P3/10;A61P7/00;A61P9/00 |
主分类号 |
A61K31/4245 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|